Pamela Vig - Jan 9, 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jan 9, 2023
Transactions value $
-$28,438
Form type
4
Date filed
3/18/2024, 05:44 PM
Previous filing
Nov 14, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$28.4K -1.38K -4.81% $20.62 27.3K Jan 9, 2023 Direct F1
holding MIRM Common Stock 75K Jan 9, 2023 By The Vig-Ancock Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.